Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5299 USD | -2.91% | -20.91% | +3.33% |
May. 09 | Earnings Flash (ATRA) ATARA BIOTHERAPEUTICS Reports Q1 Revenue $27.4M | MT |
Apr. 01 | Stifel Adjusts Atara Biotherapeutics Price Target to $2.30 From $4.80, Maintains Hold Rating | MT |
Evolution of the average Target Price on Atara Biotherapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Atara Biotherapeutics, Inc.
Stifel Nicolaus | |
Goldman Sachs | |
Evercore ISI | |
HC Wainwright | |
Mizuho Securities | |
Citigroup | |
Canaccord Genuity | |
EF Hutton | |
JPMorgan Chase | |
Stifel GMP | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- ATRA Stock
- Consensus Atara Biotherapeutics, Inc.